We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Agilent Technologies Prices $400 Million of Senior Notes

News   Sep 11, 2012

 
Agilent Technologies Prices $400 Million of Senior Notes
 
 
 

RELATED ARTICLES

Paradigm Shift for Design of Universal Vaccines

News

Killer T cells have been identified that can fight all influenza viruses – A, B and C – creating the potential for the development of a world-first universal, one-shot flu vaccine.

READ MORE

Nanopores Make Portable Peptide Mass Spectrometer a Reality

News

Scientists have developed nanopores that can be used to directly measure the mass of peptides, showing that a cheap and portable peptide mass spectrometer can be constructed using existing nanopore technology.

READ MORE

3D Protein Structure Aids Anti-cancer Drug Design

News

A research team has discovered a new mechanism for a class of anti-cancer drugs known as E1 inhibitors. Their findings reveal a novel binding site that will promote drug design of more efficient E1 inhibitors.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE